Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Miu A. C. and Benga O. (2006) Aluminum and Alzheimer's disease: a new look. J. Alzheimers 220 Dis. 10, 179–201. Mogi M., Harada M., Riederer P., Narabyashi H., Fujita J. and Nagatsu T. (1994) Interleukin-1 beta growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci. Lett. 180, 147–150. Moore D. J., West A. B., Dawson V. L. and Dawson T. M. (2005) Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57–87. Moore P. B., Day J. P., Taylor G. A., Ferrier I. N., Fifield L. K. and Edwardson J. A. (2000) Absorption of 26aluminium in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement. Geriatr. Cogn. Disord. 11, 66–69. Morens D. M., Grandinetti A., Reed D., White L. R. and Ross G. W. (1995) Cigarette smoking and protection from Parkinson’s disease: false association or etiologic clue? Neurology 45, 1041–1051. Morgante L., Rocca W. A., Di Rosa A. E., De Domenico P., Grigoletto F., Meneghini F., Reggio A., Savettieri G., Castiglione M. G., Patti F. and Di Pierri R. (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 42, 1901–1907. Morrish P. K., Sawle G. V., Brooks D. J. (1996) An [18F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease. Brain 119, 585–591. Mosharov E. V., Staal R. G., Bove J., Prou D., Hananiya A., Markov D., Poulsen N., Larsen K. E., Moore C. M., Troyer M. D., Edwards R. H., Przedborski S. and Sulzer D. (2006) Alphasynuclein overexpression increases cytosolic catecholamine concentration. J. Neurosci. 26, 9304–9311. Moumen R., Ait-Oukhatar N., Bureau F., Fleury C., Boublé D., Arhan P., Neuville D. and Viader F. (2001) Aluminium increases xanthine oxidase activity and disturbs antioxidant status in the rat. J. Trace Elem. Med. Biol. 15, 89–93.
REFERENCES Muller T., Blum-Degen D., Przuntek H. and Kuhn W. (1998) Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson’s disease. Acta Neurol. Scand. 98, 142– 144. Muñoz A. M., Rey P., Soto-Otero R., Guerra M. J. and Labandeira-García J. L. (2004) Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6- hydroxydopamine-induced degeneration. J. Neurosci. Res. 76, 551–562. Muñoz A., Rey P., Guerra M. J., Mendez-Alvarez E., Soto-Otero R., Labandeira-Garcia J. L. (2006) Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51, 112–120. Murphy C. P., Cox R. L., Harden E. A., Stevens D. A., Heye M. M. and Herzig R. H. (1992) Encephalopathy and seizures induced by intravesical alum irrigations. Bone Marrow Transplant. 10, 383–385. Muthane U. B., Swamy H. S., Satishchandra P., Subhash M. N., Rao S. and Subbakrishna D. (1994) Early onset Parkinson's disease: are juvenile- and young-onset different? Mov. Disord. 9, 539–544. Nagasawa K., Ito S., Kakuda T., Nagai K., Tamai I., Tsuji A. and Fujimoto S. (2005) Transport mechanism for aluminum citrate at the blood-brain barrier: kinetic evidence implies involvement of system Xc- in immortalized rat brain endothelial cells. Toxicol. Lett. 155, 289–296. Nagatsu T. (2002) Parkinson’s disease: changes in apoptosis-related factors suggesting possible gene therapy. J. Neural. Transm. 109, 731–745. Nagatsu T., Mogi M., Ichinose H. and Togari A. (2000) Cytokines in Parkinson’s disease. J. Neural Transm. Suppl. 58, 143–151. 221
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
- Page 268 and 269: REFERENCES Vila M. and Przedborski
- Page 270 and 271: REFERENCES Whitehead M. W., Farrar
- Page 272 and 273: REFERENCES Yokel R. A. (2002a) Alum
- Page 274: REFERENCES Zhou W., Zhu M., Wilson
REFERENCES<br />
Muller T., Blum-Degen D., Przuntek H. and Kuhn W. (1998) Interleuk<strong>in</strong>-6 levels <strong>in</strong> cerebrosp<strong>in</strong>al<br />
fluid <strong>in</strong>versely correlate to severity <strong>of</strong> Park<strong>in</strong>son’s disease. Acta Neurol. Scand. 98, 142–<br />
144.<br />
Muñoz A. M., Rey P., Soto-Otero R., Guerra M. J. and Labandeira-García J. L. (2004) Systemic<br />
adm<strong>in</strong>istration <strong>of</strong> N-acetylcyste<strong>in</strong>e protects dopam<strong>in</strong>ergic neurons aga<strong>in</strong>st 6-<br />
hydroxydopam<strong>in</strong>e-<strong>in</strong>duced degeneration. J. Neurosci. Res. 76, 551–562.<br />
Muñoz A., Rey P., Guerra M. J., Mendez-Alvarez E., Soto-Otero R., Labandeira-Garcia J. L.<br />
(2006) Reduction <strong>of</strong> dopam<strong>in</strong>ergic degeneration and <strong>oxidative</strong> <strong>stress</strong> by <strong>in</strong>hibition <strong>of</strong><br />
angiotens<strong>in</strong> convert<strong>in</strong>g enzyme <strong>in</strong> a MPTP model <strong>of</strong> park<strong>in</strong>sonism. Neuropharmacology 51,<br />
112–120.<br />
Murphy C. P., Cox R. L., Harden E. A., Stevens D. A., Heye M. M. and Herzig R. H. (1992)<br />
Encephalopathy and seizures <strong>in</strong>duced by <strong>in</strong>travesical alum irrigations. Bone Marrow<br />
Transplant. 10, 383–385.<br />
Muthane U. B., Swamy H. S., Satishchandra P., Subhash M. N., Rao S. and Subbakrishna D.<br />
(1994) Early onset Park<strong>in</strong>son's disease: are juvenile- and young-onset different? Mov.<br />
Disord. 9, 539–544.<br />
Nagasawa K., Ito S., Kakuda T., Nagai K., Tamai I., Tsuji A. and Fujimoto S. (2005) Transport<br />
mechanism for alum<strong>in</strong>um citrate at the blood-bra<strong>in</strong> barrier: k<strong>in</strong>etic evidence implies<br />
<strong>in</strong>volvement <strong>of</strong> system Xc- <strong>in</strong> immortalized rat bra<strong>in</strong> endothelial cells. Toxicol. Lett. 155,<br />
289–296.<br />
Nagatsu T. (2002) Park<strong>in</strong>son’s disease: changes <strong>in</strong> apoptosis-related factors suggest<strong>in</strong>g possible<br />
gene therapy. J. Neural. Transm. 109, 731–745.<br />
Nagatsu T., Mogi M., Ich<strong>in</strong>ose H. and Togari A. (2000) Cytok<strong>in</strong>es <strong>in</strong> Park<strong>in</strong>son’s disease. J.<br />
Neural Transm. Suppl. 58, 143–151.<br />
221
Change language